Navigation Links
Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider

Bridgewater, NJ, October 12, 2007 -- Excerpta Medica, an Elsevier business that has delivered medical communications for over six decades, has merged with corporate sibling Elsevier Interactive Solutions (EIS), an award-winning interactive health communications agency with more than a decades experience creating online marketing and educational programs for leading healthcare brands. Excerpta Medica will now be able to offer customers in the pharmaceutical and biotechnology industries a full range of comprehensive, turn-key communication solutions that combine important and timely clinical content with innovative online tools.

As the online channel becomes increasingly important to our clients, we can now provide them with seamless access to a proven pioneer in interactive health care marketing, says Greg Samios, President of Excerpta Medica. Health care organizations now have a choice: juggle work amongst several agencies for integrated campaigns, or work with us and benefit from the time- and cost-savings of having all the services they need in one organization.

To reflect the merger, EIS has changed its name to Excerpta Medica Interactive ( and will operate as a division of Excerpta Medica. Excerpta Medica Interactive will service clients globally from its offices in Toronto.


Contact: Scott Breed

Page: 1

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. What happens when Medications go wrong?
3. Teens turning to Internet for medical queries
4. Medicare Drug Deadline not to be extended
5. Medications to Prevent Relapse to Cocaine Use
6. More Elderly Take Inappropriate and Harmful Medications
7. Medications for depression
8. Robots craft medical history
9. NBE to conduct test for medical students from abroad
10. Medications linked to xerostomia and caries
11. Medication recuperates fat distribution in diabetes
Post Your Comments:
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: